NOVT logo

Novanta Inc. Stock Price

NasdaqGS:NOVT Community·US$5.3b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

NOVT Share Price Performance

US$143.96
26.33 (22.38%)
US$194.50
Fair Value
US$143.96
26.33 (22.38%)
26.0% undervalued intrinsic discount
US$194.50
Fair Value
Price US$143.96
AnalystConsensusTarget US$194.50

NOVT Community Narratives

·
Fair Value US$194.5 26.0% undervalued intrinsic discount

Robotics And Healthcare Demand Will Expand Market Opportunities

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

NOVT logo

NOVT: Future Returns Will Depend On Executing Medical Acquisition And Restructuring Strategy

Fair Value: US$194.5 26.0% undervalued intrinsic discount
4 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
2 Rewards

Novanta Inc. Key Details

US$1.0b

Revenue

US$571.0m

Cost of Revenue

US$458.7m

Gross Profit

US$396.9m

Other Expenses

US$61.8m

Earnings

Last Reported Earnings
Jul 03, 2026
Next Reporting Earnings
n/a
1.63
44.54%
6.00%
14.2%
View Full Analysis

About NOVT

Founded
1968
Employees
3000
CEO
Matthijs Glastra
WebsiteView website
www.novanta.com

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; imaging, identification and RFID solutions; advanced motion control solutions; and light engines, and integrated operating room technologies. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is based in Bedford, Massachusetts.

Recent NOVT News & Updates

Seeking Alpha Aug 23

Novanta: A Strong Year So Far, Fully Priced In

Summary Novanta completed the Riverpoint Medical acquisition, enhancing recurring consumables and medical business growth prospects. Q2 sales rose 10% to $266M with 9% organic growth and adjusted EBITDA up 16%, reflecting strong operational performance. Forward guidance projects 2026 sales of $1.135B and adjusted earnings of $3.71 per share, with Riverpoint contributing $0.18-$0.25 EPS in 2027. Despite improved fundamentals and backlog, Novanta trades at a demanding 36-37x forward earnings, keeping risk-reward only modestly improved. Read the full article on Seeking Alpha
Narrative Update Aug 22

NOVT: Future Returns Will Depend On Executing Medical Acquisition And Restructuring Strategy

Analysts have lifted their price target on Novanta to $194.50 from $182, citing updated valuation work after Q2 results and the stock's inclusion on a conviction list as key supports for the new view. Analyst Commentary Recent research updates around Novanta highlight how analysts are thinking about the stock after the latest Q2 results and its inclusion on an analyst conviction list.

Recent updates

No updates